ITM Enters Cooperation Agreement with Paul Scherrer
Enhancement of ITM’s development and manufacturing activities strengthens ITM’s position as a pioneer and leader in Targeted Radionuclide Therapy (TRT) ...
Julia Hofmann Svenja Steffen Schuster Ben Orzelek Roger Schibli Corporate Communications European Journal Of Nuclear Medicine
Source: globenewswire.com